Study of Proton Pump Inhibitors (PPI) to Prevent Strictures After Gastric Bypass Surgery
Withdrawn before enrolling · Phase 4
Conditions studied: Anastomotic Stricture, Morbid Obesity
In brief
The purpose of this study is to determine whether suppressing acid production by administration of daily proton pump inhibitors in the early post-operative period will reduce the gastrojejunal anastomosis stricture rate in patients undergoing laparoscopic gastric bypass surgery for morbid obesity.
Key facts
- Study ID
- NCT00361985
- Run by
- Weill Medical College of Cornell University
- People needed
- 0
- Starts
- 2008-01-01
- Expected to finish
- 2011-07-01
- Last updated by the study team
- 2016-11-01
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Any patient who satisfies the requirements of the Weill-Cornell Weight Loss Surgery program to undergo laparoscopic Roux-en-Y gastric bypass surgery as treatment for morbid obesity.
You may not qualify if…
- Patients with a history of ulcer disease, patients taking chronic acid suppression medicine, and patients taking NSAIDS.
Where it is running
- Weill Medical College of Cornell Unversity — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.